EpiVacCorona

EpiVacCorona Uses, Dosage, Side Effects, Food Interaction and all others data.

EpiVacCorona Vaccine, developed by the Vektor State Research Center of Virology and Biotechnology in Russia, is based on peptide-antigens that facilitate immunity to the SARS-CoV-2 virus. It is currently being tested in Phase I/II clinical trials for safety and immunogenicity (NCT04527575).

Trade Name	EpiVacCorona
Generic	EpiVacCorona
Type
Groups	Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	September 19, 2023 at 7:00 am

Innovators Monograph

You find simplified version here EpiVacCorona